Position
Bridgewater in Corcept Therapeutics Inc
Back to the book · All holders of CORT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.79M$40.31 → $86.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 279K | $9.71M | — | — | — | 0.0% |
| Q1 2026 | 38.4K | $1.55M | $40.31 | $211.7K | −$8.37M | 0.0% |
| Q2 2026 | 57.6K | $5.01M | $86.95 | $1.79M | $1.67M | 0.0% |